Mobia Medical, Inc. (NASDAQ:MOBI – Get Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totaling 827,893 shares, a growth of 140.3% from the May 31st total of 344,480 shares. Based on an average daily trading volume, of 247,511 shares, the short-interest ratio is currently 3.3 days. Currently, 2.5% of the shares of the stock are short sold.
Analyst Upgrades and Downgrades
MOBI has been the subject of several analyst reports. Wall Street Zen upgraded shares of Mobia Medical from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. The Goldman Sachs Group initiated coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $31.00 price objective for the company. BTIG Research started coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $19.00 price target on the stock. JPMorgan Chase & Co. initiated coverage on Mobia Medical in a research report on Tuesday, June 2nd. They issued an “overweight” rating and a $15.00 price objective on the stock. Finally, Wolfe Research assumed coverage on Mobia Medical in a research report on Tuesday, June 2nd. They set an “outperform” rating for the company. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Mobia Medical has an average rating of “Moderate Buy” and a consensus target price of $20.25.
View Our Latest Report on Mobia Medical
Mobia Medical Stock Up 1.0%
Mobia Medical (NASDAQ:MOBI – Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The company reported $999.00 EPS for the quarter. The firm had revenue of $12.07 million for the quarter.
Insiders Place Their Bets
In other Mobia Medical news, major shareholder Osage University Gp Iii, Llc bought 533,333 shares of Mobia Medical stock in a transaction dated Monday, May 11th. The shares were purchased at an average cost of $15.00 per share, for a total transaction of $7,999,995.00. Following the acquisition, the insider directly owned 2,006,716 shares in the company, valued at approximately $30,100,740. This represents a 36.20% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Dana G. Jr. Mead bought 7,000 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were acquired at an average price of $15.00 per share, for a total transaction of $105,000.00. Following the completion of the transaction, the director directly owned 7,000 shares in the company, valued at approximately $105,000. This represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders bought 1,273,332 shares of company stock worth $19,088,930.
Featured Articles
- Five stocks we like better than Mobia Medical
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
- Hershey Stock May Be Near a Sweet Spot as Cocoa Pressure Eases
- Comcast’s NBCUniversal Split Puts Broadband Back in Focus
Receive News & Ratings for Mobia Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobia Medical and related companies with MarketBeat.com's FREE daily email newsletter.
